IL139059A0 - Hydroxamic acid derivates as antibacterials - Google Patents

Hydroxamic acid derivates as antibacterials

Info

Publication number
IL139059A0
IL139059A0 IL13905999A IL13905999A IL139059A0 IL 139059 A0 IL139059 A0 IL 139059A0 IL 13905999 A IL13905999 A IL 13905999A IL 13905999 A IL13905999 A IL 13905999A IL 139059 A0 IL139059 A0 IL 139059A0
Authority
IL
Israel
Prior art keywords
group
antibacterials
alkyl
independently
hydroxamic acid
Prior art date
Application number
IL13905999A
Other languages
English (en)
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of IL139059A0 publication Critical patent/IL139059A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
IL13905999A 1998-05-16 1999-05-14 Hydroxamic acid derivates as antibacterials IL139059A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810464.9A GB9810464D0 (en) 1998-05-16 1998-05-16 Hydroxamic acid derivatives
PCT/GB1999/001541 WO1999059568A1 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials

Publications (1)

Publication Number Publication Date
IL139059A0 true IL139059A0 (en) 2001-11-25

Family

ID=10832125

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13905999A IL139059A0 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivates as antibacterials
IL139059A IL139059A (en) 1998-05-16 2000-10-16 Use of a history of hydroxamic acid for the preparation of antibacterial drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139059A IL139059A (en) 1998-05-16 2000-10-16 Use of a history of hydroxamic acid for the preparation of antibacterial drugs

Country Status (23)

Country Link
US (3) US6441042B1 (xx)
EP (2) EP1079819B1 (xx)
JP (1) JP2002515427A (xx)
KR (1) KR100634089B1 (xx)
CN (1) CN1300210A (xx)
AT (1) ATE347356T1 (xx)
AU (1) AU754063B2 (xx)
BR (1) BR9910488A (xx)
CA (1) CA2332713C (xx)
CY (1) CY1106452T1 (xx)
DE (1) DE69934309T2 (xx)
DK (1) DK1079819T3 (xx)
ES (1) ES2278444T3 (xx)
GB (2) GB9810464D0 (xx)
HU (1) HUP0102290A3 (xx)
IL (2) IL139059A0 (xx)
NO (1) NO20005782L (xx)
NZ (1) NZ507560A (xx)
PL (1) PL344438A1 (xx)
PT (1) PT1079819E (xx)
TR (1) TR200003376T2 (xx)
WO (1) WO1999059568A1 (xx)
ZA (1) ZA200006131B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69917221T2 (de) * 1998-02-07 2005-05-04 Vernalis (Oxford) Ltd., Abington Antibakterielle mittel
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
EP1210330B1 (en) * 1999-08-10 2005-04-20 Vernalis (Oxford) Ltd Antibacterial agents
WO2001040198A2 (fr) * 1999-11-30 2001-06-07 Aventis Pharma S.A. Derives macrocycliques de l'acide hydroxamique et leur utilisation en tant qu'antimicrobiens
FR2801591B1 (fr) * 1999-11-30 2002-03-01 Aventis Pharma Sa Derives macrocycliques de l'acide hydroxamique, leur preparation et les compositions qui les contiennent
GB9929979D0 (en) * 1999-12-17 2000-02-09 Darwin Discovery Ltd Hydroxamic acid derivatives
AU2268401A (en) * 1999-12-17 2001-06-25 Versicor Inc Novel succinate compounds, compositions and methods of use and preparation
WO2002028829A2 (en) * 2000-09-25 2002-04-11 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
ATE298565T1 (de) * 2000-11-23 2005-07-15 Vernalis Oxford Ltd N-formyl hydroxylamine derivate als inhibitoren der bakteriellen polypeptid deformylase zur behandlung von mikrobiellen infektionen
JP2004532826A (ja) * 2001-03-19 2004-10-28 スローン−ケッタリング インスティトゥート フォー カンサー リサーチ （ｓ，ｒ，ｒ）−（−）−アクチノニンおよびそのアナログの不斉合成、ならびにそれらの使用
EP1383729A4 (en) * 2001-04-05 2006-04-19 Smithkline Beecham Corp DEFORMYLASE PEPTIDE INHIBITORS
GB0128943D0 (en) * 2001-12-04 2002-01-23 Novo Pharmaceuticals De Ltd Bacterial enzyme inhibitors
JP4190862B2 (ja) * 2001-12-18 2008-12-03 シャープ株式会社 表示装置およびその駆動方法
GB0208579D0 (en) * 2002-04-13 2002-05-22 British Biotech Pharm Antibacterial agents
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
US8993641B2 (en) * 2007-11-29 2015-03-31 Innolex Investment Corporation Preservation of cosmetics, toiletry and pharmaceutical compositions
DE102011088962A1 (de) * 2011-12-19 2013-06-20 Beiersdorf Ag Wirkstoffkombinationen aus einer oder mehreren Carbonsäuren, insbesondereHydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen Hydroxamsäure sowie kosmetische oder dermatologische Zubereitungen, solcheWirkstoffkombinationen enthaltend
WO2016201288A1 (en) 2015-06-12 2016-12-15 Brown University Novel antibacterial compounds and methods of making and using same
BR112019025979B1 (pt) * 2017-06-29 2022-12-20 Kimberly-Clark Worldwide, Inc Método para inibir o crescimento microbiano em um produto, lenço umedecido, e, emulsão
CN108672095A (zh) * 2018-05-04 2018-10-19 广东省资源综合利用研究所 γ-羟基烷基羟肟酸及其制备方法与应用
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028921A (en) * 1962-01-23 1966-05-11 Ranjeet Bhagwan Singh New antibiotic
US4303662A (en) * 1980-11-24 1981-12-01 E. R. Squibb & Sons, Inc. Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
JPH0670019B2 (ja) * 1989-07-21 1994-09-07 明治製菓株式会社 新抗生物質ｓｆ２１９７ｃ物質およびその製造法
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
JPH03157372A (ja) * 1989-11-13 1991-07-05 Yamanouchi Pharmaceut Co Ltd Ｙｌ―０１８６９ｐ物質及びその製造法
WO1992022523A2 (en) * 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
CA2170158A1 (en) * 1993-08-23 1995-03-02 Roy A. Black Inhibitors of tnf-alpha secretion
JP3157372B2 (ja) 1993-11-29 2001-04-16 三洋電機株式会社 フィルタ
AU695507B2 (en) * 1994-06-22 1998-08-13 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5532265A (en) * 1994-11-30 1996-07-02 The Board Of Trustees Of The Leland Stanford Junior University Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors
GB9507799D0 (en) 1995-04-18 1995-05-31 British Biotech Pharm Metalloproteinase inhibitors
US6281245B1 (en) * 1996-10-28 2001-08-28 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
ATE290878T1 (de) * 1996-12-06 2005-04-15 Fonden Til Fremme Af Eksperime Inhibierung von invasiver remodulierung
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
DE69917221T2 (de) * 1998-02-07 2005-05-04 Vernalis (Oxford) Ltd., Abington Antibakterielle mittel
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives

Also Published As

Publication number Publication date
US6441042B1 (en) 2002-08-27
NO20005782L (no) 2001-01-15
IL139059A (en) 2006-12-31
DE69934309T2 (de) 2007-07-05
NZ507560A (en) 2003-06-30
BR9910488A (pt) 2001-01-09
PT1079819E (pt) 2007-03-30
PL344438A1 (en) 2001-11-05
CA2332713C (en) 2008-04-01
WO1999059568A1 (en) 1999-11-25
TR200003376T2 (tr) 2001-03-21
KR20010034861A (ko) 2001-04-25
DK1079819T3 (da) 2007-04-10
CY1106452T1 (el) 2011-10-12
ATE347356T1 (de) 2006-12-15
GB2353708A (en) 2001-03-07
EP1754477A3 (en) 2007-03-14
DE69934309D1 (de) 2007-01-18
US7323563B2 (en) 2008-01-29
GB0024789D0 (en) 2000-11-22
HUP0102290A2 (hu) 2001-11-28
HUP0102290A3 (en) 2001-12-28
AU3942199A (en) 1999-12-06
NO20005782D0 (no) 2000-11-15
ZA200006131B (en) 2002-01-30
JP2002515427A (ja) 2002-05-28
EP1079819B1 (en) 2006-12-06
ES2278444T3 (es) 2007-08-01
EP1079819A1 (en) 2001-03-07
US6992190B2 (en) 2006-01-31
KR100634089B1 (ko) 2006-10-17
CN1300210A (zh) 2001-06-20
AU754063B2 (en) 2002-10-31
EP1754477A2 (en) 2007-02-21
CA2332713A1 (en) 1999-11-25
US20060211732A1 (en) 2006-09-21
GB9810464D0 (en) 1998-07-15
US20020198241A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
IL139059A0 (en) Hydroxamic acid derivates as antibacterials
GB2349884A (en) Antibacterial agents
AU2001276416A1 (en) Substituted triazolopyrid(az)ines as plant treatment agents (herbicides)
BR9809531A (pt) Composições herbicidas.
ES2110673T3 (es) N-azinil-n'-(het)arilsulfonil-ureas como herbicidas.
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
IE802135L (en) Pyrazolobenzodiazepines
AP9701140A0 (en) New hydroximic acid derivatives.
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
ES2059918T3 (es) Metazacloro monoclinico y procedimiento para su fabricacion.
AU740079C (en) Antirheumatic agents
ATE253356T1 (de) N-formyl hydroxylamin derivate als antibakterielle mittel
DE60006053D1 (de) 2-Aryloxy-4-methyl-6-pyrazol-1-yl-pyridine wirksam als Herbizide
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
EP1570837A4 (en) DENDRIT EXTENSION INHIBITOR FOR MELANOZYT AND SKIN PREPARATION FOR EXTERNAL USE, INCLUDING THAT SAME.
DK0814662T3 (da) Blandede herbicide sammensætninger
AU1978700A (en) Coloring agents comprising manganese cations
ATE204294T1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
CA2278553A1 (en) Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
BR9901206A (pt) Derivados de pirimidinona.
AU5498098A (en) Tetrahydrofurans
EP1486489A3 (en) Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
CO4650115A1 (es) Nuevos derivados del acido hidroximico para uso en la pro- teccion de las plantas

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees